Alpaslan Tasdogan

4.1k total citations · 2 hit papers
52 papers, 1.9k citations indexed

About

Alpaslan Tasdogan is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Alpaslan Tasdogan has authored 52 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 14 papers in Immunology and 12 papers in Cancer Research. Recurrent topics in Alpaslan Tasdogan's work include Cancer, Hypoxia, and Metabolism (10 papers), Epigenetics and DNA Methylation (7 papers) and Immune Cell Function and Interaction (5 papers). Alpaslan Tasdogan is often cited by papers focused on Cancer, Hypoxia, and Metabolism (10 papers), Epigenetics and DNA Methylation (7 papers) and Immune Cell Function and Interaction (5 papers). Alpaslan Tasdogan collaborates with scholars based in Germany, United States and France. Alpaslan Tasdogan's co-authors include Sean J. Morrison, Zhiyu Zhao, Thomas P. Mathews, Jessalyn M. Ubellacker, Bo Shen, Zhimin Gu, Vijayashree Ramesh, Misty S. Martin-Sandoval, Evann C. Mitchell and Alison B. Durham and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Alpaslan Tasdogan

47 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lymph protects metastasizing melanoma cells from ferroptosis

2020 625 citations Jessalyn M. Ubellacker, Alpaslan Tasdogan et al. Nature profile →
Metabolic heterogeneity confers differences in melanoma metastatic potential

2019 355 citations Alpaslan Tasdogan, Brandon Faubert et al. Nature profile →

Peers

Countries citing papers authored by Alpaslan Tasdogan

Since Specialization

Citations

This map shows the geographic impact of Alpaslan Tasdogan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alpaslan Tasdogan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alpaslan Tasdogan more than expected).

Fields of papers citing papers by Alpaslan Tasdogan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alpaslan Tasdogan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alpaslan Tasdogan. The network helps show where Alpaslan Tasdogan may publish in the future.

Co-authorship network of co-authors of Alpaslan Tasdogan

This figure shows the co-authorship network connecting the top 25 collaborators of Alpaslan Tasdogan. A scholar is included among the top collaborators of Alpaslan Tasdogan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alpaslan Tasdogan. Alpaslan Tasdogan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Amitriptyline inhibits Plasmodium development in infected red blood cells by modulating sphingolipid metabolism and glucose uptake 2025 ·Biomedicine & Pharmacotherapy ·(unknown), (unknown), (unknown), Fabian Schumacher, (unknown), (unknown), (unknown), Luiza Martins Nascentes Melo, Nadine Beckmann, (unknown), (unknown), Burkhard Kleuser, Alpaslan Tasdogan, Erich Gulbins, Alexander Carpinteiro, Robert Klopfleisch, Jan Buer, Astrid M. Westendorf, Kai Matuschewski, Wiebke Hansen	0
2	Cutaneous melanoma 2025 ·Nature Reviews Disease Primers ·Alpaslan Tasdogan, Ryan J. Sullivan, Alexander Katalinic, Célèste Lebbé, (unknown), Susana Puig, Lonneke V. van de Poll‐Franse, Daniela Massi, Dirk Schadendorf	17
3	The molecular blueprint of targeted radionuclide therapy 2025 ·Nature Reviews Clinical Oncology ·Irina Primac, Kevin Tabury, Alpaslan Tasdogan, Sarah Baatout, Ken Herrmann	1
4	Data from Mitochondrial Glutathione Import Enables Breast Cancer Metastasis via Integrated Stress Response Signaling 2025 ·(unknown), (unknown), (unknown), (unknown), Artem Khan, Gökhan Ünlü, (unknown), Rebecca C. Timson, (unknown), (unknown), (unknown), Luiza Martins Nascentes Melo, (unknown), Olca Baştürk, Albert Sickmann, Erol C. Bayraktar, Richard Possemato, Alpaslan Tasdogan, Kıvanç Birsoy	0
5	Aldolase A: the broker of glycolysis 2025 ·Nature Metabolism ·Luiza Martins Nascentes Melo, (unknown), Alpaslan Tasdogan	1
6	Constitutive expression of the transcriptional co-activator IκBζ promotes melanoma growth and immunotherapy resistance 2025 ·Nature Communications ·(unknown), (unknown), Matthias Klein, (unknown), Maximilian Haist, (unknown), (unknown), Tobias Sinnberg, Antje Sucker, (unknown), (unknown), Alpaslan Tasdogan, Andrea Tuettenberg, Matthias M. Gaida, Carsten Deppermann, Henner Stege, Dirk Schadendorf, Stephan Grabbe, Klaus Schulze‐Osthoff, (unknown)	0
7	Mitochondrial Glutathione Import Enables Breast Cancer Metastasis via Integrated Stress Response Signaling 2025 ·Cancer Discovery ·(unknown), (unknown), (unknown), (unknown), Artem Khan, Gökhan Ünlü, (unknown), Rebecca C. Timson, (unknown), (unknown), (unknown), Luiza Martins Nascentes Melo, (unknown), Olca Baştürk, Albert Sickmann, Erol C. Bayraktar, Richard Possemato, Alpaslan Tasdogan, Kıvanç Birsoy	0
8	Approaches to stable isotope tracing and in vivo metabolomics in the cancer clinic 2025 ·The EMBO Journal ·Brandon Faubert, Alpaslan Tasdogan	1
9	Retrotransposons are co-opted to activate hematopoietic stem cells and erythropoiesis 2024 ·Science ·(unknown), (unknown), Zhiyu Zhao, (unknown), Antonella Iannaccone, (unknown), (unknown), Annamaria Spina, (unknown), Alexandra Gellhaus, Dirk Schadendorf, Rainer Kimmig, Marcel Mettlen, Alpaslan Tasdogan, Sean J. Morrison	8
10	The Interplay between Metabolic Adaptations and Diet in Cancer Immunotherapy 2024 ·Clinical Cancer Research ·(unknown), Natalie Wagner, Jan‐Malte Placke, Selma Ugurel, Alpaslan Tasdogan	2
11	Comparison of visual diagnostic accuracy of dermatologists practicing in Germany in patients with light skin and skin of color 2024 ·Scientific Reports ·(unknown), (unknown), (unknown), Jan‐Malte Placke, (unknown), (unknown), Alpaslan Tasdogan, Dirk Schadendorf, Selma Ugurel, Joachim Dissemond, Wiebke Sondermann	3
12	1168P Tumor PD-L1 predicts the outcome of PD-1-based immunotherapy in metastatic melanoma depending on the type of tissue examined 2023 ·Annals of Oncology ·(unknown), Martin Kimmig, Klaus Griewank, Eva Hadaschik, Rudolf Herbst, (unknown), Jochen Utikal, Claudia Pfoehler, Jens Ulrich, Alexander Kreuter, Peter Mohr, Ralf Gutzmer, Friedegund Meier, Edgar Dippel, Julia Welzel, Jürgen C. Becker, Michael Weichenthal, Alpaslan Tasdogan, Dirk Schadendorf, (unknown)	1
13	Emerging metabolomic tools to study cancer metastasis 2022 ·Trends in cancer ·Luiza Martins Nascentes Melo, Nicholas P. Lesner, Marie Sabatier, Jessalyn M. Ubellacker, Alpaslan Tasdogan	37
14	Advancements in melanoma cancer metastasis models 2022 ·Pigment Cell & Melanoma Research ·Luiza Martins Nascentes Melo, Suresh Kumar, (unknown), (unknown), (unknown), Dirk Schadendorf, Jessalyn M. Ubellacker, Alpaslan Tasdogan	10
15	The effect of parathyroid hormone on osteogenesis is mediated partly by osteolectin 2021 ·Proceedings of the National Academy of Sciences ·Jingzhu Zhang, Adi Cohen, Bo Shen, Liming Du, Alpaslan Tasdogan, Zhiyu Zhao, Elizabeth Shane, Sean J. Morrison	24
16	Stable isotope tracing to assess tumor metabolism in vivo 2021 ·Nature Protocols ·Brandon Faubert, Alpaslan Tasdogan, Sean J. Morrison, Thomas P. Mathews, Ralph J. DeBerardinis	50
17	Isotope tracing reveals glycolysis and oxidative metabolism in childhood tumors of multiple histologies 2021 ·Med ·(unknown), Panayotis Pachnis, Alpaslan Tasdogan, Brandon Faubert, Lauren G. Zacharias, Hieu Vu, (unknown), Allison Johnson, Fang Huang, (unknown), Zhiyu Zhao, Thomas P. Mathews, Tanya Watt, Patrick J. Leavey, Ralph J. DeBerardinis	29
18	Lymph protects metastasizing melanoma cells from ferroptosis breakdown → 2020 ·Nature ·Jessalyn M. Ubellacker, Alpaslan Tasdogan, Vijayashree Ramesh, Bo Shen, Evann C. Mitchell, Misty S. Martin-Sandoval, Zhimin Gu, Michael L. McCormick, Alison B. Durham, Douglas R. Spitz, Zhiyu Zhao, Thomas P. Mathews, Sean J. Morrison	625
19	The abundance of metabolites related to protein methylation correlates with the metastatic capacity of human melanoma xenografts 2017 ·Science Advances ·Xiaolei Shi, Alpaslan Tasdogan, Fang Huang, Zeping Hu, Sean J. Morrison, Ralph J. DeBerardinis	37
20	Distinct Homotypic B-Cell Receptor Interactions Shape The Outcome Of Chronic Lymphocytic Leukemia 2016 ·Haematologica ·(unknown), Claudia Minici, (unknown), (unknown), Dina Schneider, Alpaslan Tasdogan, (unknown), Andreas Agathangelidis, Stavroula Ntoufa, Nicholas Chiorazzi, Hassan Jumaa, Κώστας Σταματόπουλος, Massimo Degano, Paolo Ghia	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact